Pharmaceuticals
-
The CFO: ‘The pipeline drives value; I rarely get questions on cash flow,’ says Roche finance chief Dr Alan Hippe
The pharmaceutical company’s CFO on an unconventional path to the C-suite, what it means when investors trust you can generate enough cash and why corporate purpose is part of the fabric of Roche When you’re the CFO of a 261.6bn Swiss franc ($333.5 bn) market cap pharmaceutical giant like Roche, you don’t necessarily have […]
Published 3 hours ago -
Why I turned down tickets to the opening of the Paris Olympics: the importance of saying ‘no’ in IR
A polite ‘no’ lets you focus on what only the IR team can do – and frees up much-needed time – argues Thomas Kudsk Larsen Last year, I turned down tickets to the opening ceremony of the Paris Olympics. While many might think I was crazy to pass up such an opportunity (I definitely wasn’t, […]
-
Why Brian Thompson’s killing has prompted companies to think about executive safety and corporate purpose
‘Executive security used to be something of a hard sell,’ says Iylia Lavatelli, a former close-protection security provider, now working at operational resilience firm Restrata, talking about budget as well as executive willingness playing their parts in what any security manager can achieve. That, of course, changed with the shooting of Brian Thompson, UnitedHealthcare CEO, in New York last week. The news today is of companies scrambling to organize their security and senior profiles being removed from corporate websites – health insurance firms in particular
